Detalhe da pesquisa
1.
Microglial depletion abolishes ischemic preconditioning in white matter.
Glia
; 70(4): 661-674, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34939240
2.
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.
Proc Natl Acad Sci U S A
; 111(1): 409-14, 2014 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24367102
3.
Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring.
Front Hum Neurosci
; 12: 226, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29915533
4.
Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS.
Brain Behav
; 7(2): e00614, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28239524
5.
Reduced rich-club connectivity is related to disability in primary progressive MS.
Neurol Neuroimmunol Neuroinflamm
; 4(5): e375, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28804744
6.
Dystonia with aphonia, slow horizontal saccades, epilepsy and photic myoclonus: a novel syndrome?
Parkinsonism Relat Disord
; 20(3): 328-31, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24359844
7.
Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS.
Neurol Neuroimmunol Neuroinflamm
; 4(2): e325, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28210661
8.
Ruxolitinib treatment in a patient with neuromyelitis optica: A case report.
Neurol Neuroimmunol Neuroinflamm
; 4(2): e328, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28203617